Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome
Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome
Not yet recruiting · NCT07146880 · Registry updated 2025-09-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome | Arrhythmias, Cardiac, Brugada syndrome, Cardiac Conduction System Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, heart disorder, hereditary disease | Not yet recruiting | Phase 2 | 2025-09-12 | NCT07146880 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Taiwan University Hospital | 540 |
| Stanford University | 620 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Taiwan University Hospital | Taipei | Taiwan | 9 |